MultiHance® 9 Image Library 9 Maravilla et al. 51F Metastatic Lung Cancer

MultiHance® (gadobenate dimeglumine) injection, 529 mg/mL Improves Visualization and Enhancement of Lesions vs. Magnevist® (gadopentetate dimeglumine)1

Maravilla et al.
51-year-old woman with metastatic lung cancer

These are representative images from reference studies; individual results may vary.

Reference: 1. Maravilla KR, Maldjian JA, Schmalfuss IM, et al. Contrast enhancement of central nervous system lesions: multicenter intraindividual crossover comparative study of two MR contrast agents. Radiology. 2006;240(2):389-400.

More cases that may interest you